BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 1106934)

  • 21. Carbamazepine vs phenytoin. A controlled clinical trial in focal motor and generalized epilepsy.
    Kosteljanetz M; Christiansen J; Dam AM; Hansen BS; Lyon BB; Pedersen H; Dam M
    Arch Neurol; 1979 Jan; 36(1):22-4. PubMed ID: 105689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic effects of phenytoin, phenobarbital, and carbamazepine examined in kindling cat preparations.
    Wada JA; Sato M; Wake A; Green JR; Troupin AS
    Arch Neurol; 1976 Jun; 33(6):426-34. PubMed ID: 180934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results of statistical analysis with a computer of the median effective dose and plasma levels of drugs in the treatment of epilepsy].
    Oller L; Lagunas Hernandez MA; Russi Tintore A; Sabater Tobella J; Oller Daurella L
    Arch Neurobiol (Madr); 1977; 40(1):37-46. PubMed ID: 856097
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of anticonvulsant drugs which induce liver microsomal enzymes on derived and ingested phenobarbitone levels.
    Callaghan N; Feely M; Duggan F; O'Callaghan M; Seldrup J
    Acta Neurol Scand; 1977 Jul; 56(1):1-6. PubMed ID: 878841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clorazepate and phenobarbital as antiepileptic drugs: a double-blind study.
    Wilensky AJ; Ojemann LM; Temkin NR; Troupin AS; Dodrill CB
    Neurology; 1981 Oct; 31(10):1271-6. PubMed ID: 6125918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients.
    Yegnanarayan R; Mahesh SD; Sangle S
    Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development, validation and clinical application of an online-SPE-LC-HRMS/MS for simultaneous quantification of phenobarbital, phenytoin, carbamazepine, and its active metabolite carbamazepine 10,11-epoxide.
    Qu L; Fan Y; Wang W; Ma K; Yin Z
    Talanta; 2016 Sep; 158():77-88. PubMed ID: 27343581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of blood levels of antiepileptic drugs in clinical practice.
    Kutt H
    Pediatrics; 1974 Apr; 53(4):557-60. PubMed ID: 4595906
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimisation of antiepileptic drug therapy. The importance of serum drug concentration monitoring.
    Yukawa E
    Clin Pharmacokinet; 1996 Aug; 31(2):120-30. PubMed ID: 8853934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of phenobarbital and diphenylhydantoin on plasma carbamazepine levels in patients with epilepsy.
    Christiansen J; Dam M
    Acta Neurol Scand; 1973; 49(4):543-6. PubMed ID: 4773786
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Course of chronic focal epilepsy resistant to anticonvulsant treatment.
    Bauer J; Burr W
    Seizure; 2001 Jun; 10(4):239-46. PubMed ID: 11466018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of coadministered antiepileptic drugs on serum phenobarbital concentrations in epileptic patients: quantitative analysis based on a suitable transforming factor.
    Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S
    Biol Pharm Bull; 2004 Dec; 27(12):2000-5. PubMed ID: 15577220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic monitoring of antiepileptic drugs for epilepsy.
    Tomson T; Dahl ML; Kimland E
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002216. PubMed ID: 17253477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopharmacologic study of blood carbamazepine levels in a group of epileptic patients].
    Testa G; Ermani M; Giaretta D; Pellegrini A; Paleari C
    Riv Neurol; 1980; 50(4):241-52. PubMed ID: 7466220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The medical treatment of epilepsy: maintenance of drug therapy.
    Livingston S; Pruce I; Pauli LL
    Pediatr Ann; 1979 Apr; 8(4):232-54. PubMed ID: 379769
    [No Abstract]   [Full Text] [Related]  

  • 38. Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in children.
    Hug G; McGraw CA; Bates SR; Landrigan EA
    J Pediatr; 1991 Nov; 119(5):799-802. PubMed ID: 1941389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbamazepine for epilepsy. A controlled prospective evaluation.
    Cereghino JJ; Brock JT; Van Meter JC; Penry JK; Smith LD; White BG
    Neurology; 1974 May; 24(5):401-10. PubMed ID: 4207990
    [No Abstract]   [Full Text] [Related]  

  • 40. Measuring anti-convulsant levels in the accident and emergency department.
    McGlone R; Pritty P
    Arch Emerg Med; 1986 Jun; 3(2):141-3. PubMed ID: 3730081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.